July 25, 2007 - Outpatient Care Technology wants to recognize and highlight cancer treatment centers that creatively and effectively use intensity modulated and image guided radiation therapy (IMRT and IGRT) technology to deliver high-quality patient care. But we need you to tell us who these influential market leaders are. Please nominate as many worthy IMRT/IGRT cancer treatment centers as you’d like by clicking on the green button in the left-hand column of the front page of OPCT Online (www.opctonline.net). Based on the nominations we receive from you, we’ll select five to profile on why they are so successful. Look for the green button on the left and vote often. Nominations must include measurable and tangible details in customer service, innovation, operational efficiency and teamwork. But hurry; the deadline for consideration is Monday, July 30.
If you enjoy this content, please share it with a colleague
Related Content
June 7, 2022 — Two-year results from the Dysphagia-Aspiration Related Structures (DARS) trial, which is funded by Cancer ...
May 19, 2022 — Brainlab announced that clinicians at UZ Brussel are the first to treat patients with the company’s new ...
August 27, 2021 — For decades, the National Comprehensive Cancer Network (NCCN) recommended forgoing post-lumpectomy ...
June 10, 2020 — A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides ...
April 16, 2020 — RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy ...
February 11, 2020 — Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive ...
December 12, 2019 — Philips and the Regional Medical Center (RMC) announced a strategic 5-year partnership agreement ...
October 22, 2019 — The American Society for Radiation Oncology (ASTRO) and the American College of Radiology (ACR) ...
ViewRay Inc. announced today that patient treatments are scheduled to begin in Boston with ViewRay's MRIdian Linac System at Dana-Farber/Brigham and Women's Cancer Center. The MRIdian provides for the delivery of radiation therapy to targeted tumors while simultaneously providing continuous magnetic resonance imaging (MRI).
At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, being held Sept. 15-18 in Chicago, Varian announced Ethos therapy, an artificial intelligence (AI)-driven holistic solution designed to increase the capability, flexibility and efficiency of radiotherapy. This new solution is designed to deliver an entire adaptive treatment in a typical 15-minute timeslot, from patient setup through treatment delivery.